Christopher Pierce

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Brian Piper, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Pierce:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prelude Therapeutics Inc EVP and Chief of Business Oper Common Stock 3,750 $14,138 $3.77 02 Sep 2021 Direct
Prelude Therapeutics Inc EVP and Chief of Business Oper Employee Stock Option (right to buy) 207,796 02 Sep 2021 Direct

Insider Reports Filed by Christopher Pierce

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRLD Prelude Therapeutics Inc 02 Sep 2021 5 -$490,043 4 EVP and Chief of Business Oper 07 Sep 2021, 19:17
PRLD Prelude Therapeutics Inc 20 Jul 2021 1 $0 4 EVP and Chief of Business Oper 22 Jul 2021, 18:11